Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dade Behring to distribute ZymeTx influenza diagnostic:

This article was originally published in Clinica

Executive Summary

Dade Behring is to handle distribution for ZymeTx' ZstatFlu influenza diagnostic to 25,000 US hospital and reference laboratories. ZymeTx claimed a 50% share of the 230,000 point-of-care tests administered in physicians' offices last year, but said the reference labs conducted more than twice as many tests. With the advent of effective anti-flu therapeutics, that market is predicted to grow to 20 million prescriptions by 2004/2005, with a potential one-to-one ratio between diagnostics and therapeutics, according to ZymeTx.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074719

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel